News
Axela Inc. announces next generation instrument development agreement with Kangaroo Design and Israeli joint venture partners
TORONTO, CANADA, May 24, 2010
Axela Inc. and Kangaroo Design & Innovation, Inc. are pleased to announce a collaboration for the design and development of an extended capability version of the dotLab® Research System and additional diagnostic devices. This engineering and product development work will utilize Kangaroo's Toronto office in partnership with an established network of prominent Israeli engineering teams and manufacturers. These include Borsuk Contract Manufacturing, Novel Technologies Engineering, Rational Systems, S2P Solutions to Products Ltd, Or Mechanics, and others.
“The team at Kangaroo has made a significant contribution to the design of our award- winning Ziplex® and dotLab™ Products” said Rocky Ganske, CEO of Axela Inc. “We look forward to working with them on this next generation of tools that transition multiplex biomarker analysis from research into diagnostics.”
Additionally, Axela and Kangaroo-Borsuk-Toronto (KBT) Contract Manufacturing announce the establishment of a Canadian instrument service depot within the KBT facility in Toronto to support the growing installed base of dotLab® Systems.
Lahv Gil, CEO of Kangaroo commented: “This agreement reinforces our focus on the medical devices, biotech and life science markets, and supports our corporate mission to facilitate products and services that improve quality of life and/or decrease mortality and morbidity rates.”
About Axela Inc.:
Axela provides a powerful new approach to DNA, RNA and protein analysis that will revolutionize multiplex biomarker testing in clinical research and diagnostics. Axela’s commercial research products significantly improve the amount and quality of information derived from traditional assays. This approach shortens time to result, greatly simplifies multiplexing and provides access to unique categories of markers that form a pipeline of future diagnostic offerings. Axela operates from its ISO 13485 certified facilities in Toronto and its major investor is VenGrowth Private Equity Partners Inc.
About Kangaroo Design and Innovation:
Kanagroo is a product development and commercialization enterprise with a multidisciplinary team of designers, engineers and business strategists. Kangaroo's business model includes partnerships, client-services and incubation with a focus on human-centric design, optimized performance and business goals. KDI offers seamless integration from concept through the various prototyping and development stages, incorporating both strategic and operational perspectives. Kangaroo then manufactures and delivers prototypes and refines the design through to short run and serial manufacturing within a QMS environment. The Kangaroo and KBT approach is collaborative and integrated, maximizing value from all available resources.
About KBT Contract manufacturing:
KBT Contract manufacturing is a joint venture between Kangaroo Design and Innovation of Toronto and Borsuk Contract Manufacturing of Israel. KBT leverages the expertise and infrastructures of both organizations to offer a seamless transition from the design and development environment into the early production and serial manufacturing environments. KBT offers an agile and responsive facility for NPI (new product introduction) in the Toronto area adjacent to Kangaroo where clients can access a swift response team for changes and modifications during the early production stages of the product.
Contacts:
Paul Smith, VP Business Development
Axela Inc.
+1 (416) 798-1625 x302
p.smith@axela.com
www.axela.com www.xceedmolecular.com
Lahav Gil, CEO and Director of Design
Kangaroo Design & Innovation Office: 416 653 9031 ext 222
Israel office: 972 4 9824876
www.kangaroodesign.net www.kbtmanufacturing.com